Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | APH | AVGO |
|---|---|---|
| Price | $82.61 | $349.65 |
| Change today | ▲ 0.51% | ▼ 1.50% |
| Market cap | $203.71B | $1.67T |
| Return, 3 months | +1.5% | -8.5% |
| Return, year to date | +22.7% | +1.4% |
| Return, 1 year | +34.9% | +3.6% |
| P/E (TTM) | 41.3 | 44.6 |
| P/B | 13.2 | 16.7 |
| P/E percentile vs own 5y | 63rd | 51st |
| Dividend yield | 0.55% | 0.73% |
| Revenue growth (YoY, latest qtr) | +55.0% | +85.5% |
| Net profit growth (YoY) | +62.1% | +216.1% |
| Gross margin | 38.5% | 68.8% |
| Operating margin | 27.7% | 48.5% |
| Net margin | 17.7% | 42.9% |
| Return on equity | 38.1% | 44.2% |
| Analyst target vs. price | +21.9% | +50.3% |
| Analyst buy share | 89% | 93% |
| RSI (14) | 53 | 45 |
| 30-day volatility | 42.1% | 37.2% |
| Max drawdown, 1 year | -28.2% | -29.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.